Press release
Adult Malignant Glioma Therapeutics Market Forecast 2025-2034: Analysing Major Trends, Opportunities, and Growth Drivers
Adult Malignant Glioma Therapeutics Market Size
The escalation in brain tumor incidences is anticipated to fuel the expansion of the adult malignant glioma therapeutics market. Brain tumors result from an atypical proliferation of tissue that appears to be unaffected by the normal cellular regulatory systems, leading to rogue and unrestrained cell growth and division. Adult malignant glioma, a variant of brain tumors, is characterized by abnormal and uncontrolled cellular proliferation. The therapeutic approach towards adult malignant glioma involves a combination of surgery, radiation therapy, and chemotherapy. In the context of a report by the American Cancer Society, a nonprofit cancer advocacy organization based in the US, a surge in cancer cases related to the brain and nervous system was recorded in January 2023, to 24,810 from 23,890 in 2020, marking a growth rate of 3.85%. As such, the rising incidences of brain tumors are propelling the adult malignant glioma therapeutics market forward. Market Driver for Adult Malignant Glioma Therapeutics: The Contribution of Government Funding to Advancements in Therapeutics
Get Your Adult Malignant Glioma Therapeutics Market Report Here:
https://www.thebusinessresearchcompany.com/report/adult-malignant-glioma-therapeutics-global-market-report
What Is the projected market size and growth rate for the adult malignant glioma therapeutics market?
In recent years, the market size for adult malignant glioma therapeutics has seen a swift expansion. The market size is predicted to rise from $2.25 billion in 2024 to $2.48 billion in 2025, with a compound annual growth rate (CAGR) of 10.4%. The growth experienced in the historical period can be credited to factors such as higher incidence rates, patient advocacy drives, and the advancement in personalized medicine approaches.
In the coming years, the market size for adult malignant glioma therapeutics is predicted to experience significant expansion. The market is forecasted to increase to $3.55 billion by 2029, with a compound annual growth rate (CAGR) of 9.4%. This growth during the projected period can be credited to improvements in immunotherapy, targeted treatments, the discovery of biomarkers, the application of liquid biopsy, and extended access programs. The forecast period will also witness key trends including a patient-focused approach to drug development, accelerated track and breakthrough designation, advancements in drug delivery systems, joint research initiatives, and the incorporation of artificial intelligence.
Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13178&type=smp
What new trends are reshaping the adult malignant glioma therapeutics market and its opportunities?
Key businesses in the adult malignant glioma therapeutics market are focusing on the production of innovative goods such as small molecule targeted degraders, in an effort to improve customer service reliability. These unique drugs employ small molecules to trigger specific protein degeneration by focusing on the target protein and an E3 ubiquitin ligase. An example of this is Beactica Therapeutics AB, a precision oncology company based in Sweden, which got approval for an orphan drug designation by the U.S. Food and Drug Administration (FDA) in February 2023 for BEA-17- a treatment for glioblastoma (GBM). BEA-17 is a small-molecule targeted degrader designed specifically to degrade the epigenetic enzyme LSD1 and its associated co-factor CoREST, both of which have been implicated in the development of several kinds of cancer, including GBM. The functionality of BEA-17 involves the degradation of LSD1 and CoREST resulting in the re-establishment of tumor suppressor genes and the hindrance of cancer cell proliferation.
What major market segments define the scope and growth of the adult malignant glioma therapeutics market?
The adult malignant glioma therapeutics market covered in this report is segmented -
1) By Type Of Disease: Glioblastoma Multiforme, Anaplastic Astrocytoma, Anaplastic Oligodendroglioma, Anaplastic Oligoastrocytoma, Other Types
2) By Therapy: Chemotherapy, Targeted Therapy, Radiotherapy, Other Therapies
3) By End-User: Hospitals, Specialty Clinics, Cancer And Radiation Therapy Centers, Other End Users
Subsegments:
1) By Glioblastoma Multiforme: Standard Treatments, Experimental Therapies
2) By Anaplastic Astrocytoma: Chemotherapy Options, Targeted Therapies
3) By Anaplastic Oligodendroglioma: Radiation Therapy, Combination Therapies
4) By Anaplastic Oligoastrocytoma: Surgical Interventions, Adjuvant Therapies
5) By Other Types: Rare Gliomas, Emerging Therapies
Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13178
Which region dominates the adult malignant glioma therapeutics market?
North America was the largest region in the adult malignant glioma therapeutics market in 2024. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the adult malignant glioma therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Which key market leaders are driving the adult malignant glioma therapeutics industry growth?
Major companies operating in the adult malignant glioma therapeutics market report are Johnson & Johnson Private Limited, Pfizer Inc., Bio-Rad Laboratories Inc., F. Hoffmann-La Roche Ltd., Allergan PLC, AbbVie Inc., Novartis AG, Bayer AG, Merck & Co Inc., GlaxoSmithKline PLC, Bristol-Myers Squibb Company, Abbott Laboratories, AstraZeneca PLC, Eli Lilly and Company, Amgen Inc., Teva Pharmaceutical Industries Ltd., GT Medical Technologies Inc., Lupin Limited, Mylan NV, Sanofi SA, Bausch Health Companies Inc., Sun Pharmaceutical Industries Ltd., Aurobindo Pharma Limited, Genetech Inc., Amneal Pharmaceuticals LLC, Emcure Pharmaceuticals Limited, Novocure Ltd., Arbour Pharmaceuticals LLC, Basilea Pharmaceuticals Ltd.
Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/sample.aspx?id=13178&type=smp
What Is Covered In The Adult Malignant Glioma Therapeutics Global Market Report?
• Market Size Forecast: Examine the adult malignant glioma therapeutics market size across key regions, countries, product categories, and applications.
• Segmentation Insights: Identify and classify subsegments within the adult malignant glioma therapeutics market for a structured understanding.
• Key Players Overview: Analyze major players in the adult malignant glioma therapeutics market, including their market value, share, and competitive positioning.
• Growth Trends Exploration: Assess individual growth patterns and future opportunities in the adult malignant glioma therapeutics market.
• Segment Contributions: Evaluate how different segments drive overall growth in the adult malignant glioma therapeutics market.
• Growth Factors: Highlight key drivers and opportunities influencing the expansion of the adult malignant glioma therapeutics market.
• Industry Challenges: Identify potential risks and obstacles affecting the adult malignant glioma therapeutics market.
• Competitive Landscape: Review strategic developments in the adult malignant glioma therapeutics market, including expansions, agreements, and new product launches.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Adult Malignant Glioma Therapeutics Market Forecast 2025-2034: Analysing Major Trends, Opportunities, and Growth Drivers here
News-ID: 3903180 • Views: …
More Releases from The Business Research Company
Company Registration Service Market Landscape 2025: Forecast Data and Growth Str …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Company Registration Service Market Through 2025?
The market size for company registration services has seen robust growth in the recent past. The market is projected to expand from $10.67 billion in 2024 to $11.55 billion in 2025, exhibiting a compound annual growth…
Comprehensive 2025 Commercial Toilet Partition Market Overview: Trends, Forecast …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Commercial Toilet Partition Market Through 2025?
In recent years, the market size for commercial toilet partitions has significantly expanded. The forecast predicts a rise from $1.82 billion in 2024 to $1.95 billion in 2025, with a compound annual growth rate (CAGR) of…
Key Trends Influencing the Growth of the Commercial Insurance For Small And Medi …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Commercial Insurance For Small And Medium-Sized Enterprises (SMEs) Market Through 2025?
The market size of commercial insurance for small and medium-sized enterprises (SMEs) has seen substantial growth over the recent years. A rise from $111.83 billion in 2024 to $119.76 billion in…
Growing Focus On Reducing Greenhouse Gas Emissions Driving The Market Growth Due …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Combustion Emissions Analyzer Market Through 2025?
In the past few years, the market size for combustion emissions analyzer has seen robust growth. It is projected to increase from $1.02 billion in 2024 to $1.09 billion in 2025, with a compound annual growth…
More Releases for Therapeutics
Adrenomyeloneuropathy Market: Epidemiology, Therapies, Companies, DelveInsight | …
Adrenomyeloneuropathy emerging therapies are expected to boost the Adrenomyeloneuropathy Market in the upcoming years.
DelveInsight has launched a new report on "Adrenomyeloneuropathy - Market Insights, Epidemiology, and Market Forecast-2034" that delivers an in-depth understanding of the Adrenomyeloneuropathy, historical and forecasted epidemiology as well as the Adrenomyeloneuropathy market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
Discover about the Adrenomyeloneuropathy market report @ https://www.delveinsight.com/report-store/adrenomyeloneuropathy-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=kpr
Some of the…
Pompe Disease Market: Epidemiology, Therapies, Companies, DelveInsight | Genzyme …
Pompe Disease emerging therapies, such as MYOZYME (alglucosidase alfa), LUMIZYME, AAV2/8-LSPhGAA, Avalglucosidase alfa, and others, are expected to boost the Pompe Disease Market in the upcoming years.
DelveInsight has launched a new report on "Pompe Disease - Market Insights, Epidemiology, and Market Forecast-2034" that delivers an in-depth understanding of the Pompe Disease, historical and forecasted epidemiology as well as the Pompe Disease market trends in the United States, EU5 (Germany, Spain,…
Dark Genome Therapeutics Market Deep Research Report with Forecast to 2032 | myN …
The qualitative latest Research report (2025-2032) on the Dark Genome Therapeutics Market by Coherent Market Insights Provides a deep dive into key market trends, drivers, challenges, and the competitive landscape. It analyzes market size, revenue, production, and CAGR using validated methodologies to ensure precision. The report highlights tech innovation, pricing trends, consumer behavior, and investment potential - empowering businesses to make informed, strategic moves.
Request a Sample Copy: https://www.coherentmarketresearch.com/samplepages/133611
Focused on growth…
Hodgkin's lymphoma Therapeutics Market Size Report 2032 | Affimed Therapeutics, …
DelveInsight's "Hodgkin's Lymphoma Market Insights, Epidemiology, and Market Forecast - 2032" report delivers an in-depth understanding of the Hodgkin's Lymphoma, historical and forecasted epidemiology as well as the Hodgkin's Lymphoma market trends in the United States, EU4 (Germany, Spain, Italy, and France) and the United kingdom and Japan.
Discover Key Insights into the Hodgkin's lymphoma Market with DelveInsight's In-Depth Report @ Hodgkin's lymphoma Market Size- https://www.delveinsight.com/sample-request/hodgkins-lymphoma-hl-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Key Takeaways from the Hodgkin's…
CRISPR Therapies Pipeline 2024 | Intellia Therapeutics, CRISPR therapeutics, Rep …
DelveInsight's, "CRISPR Therapies Pipeline Insight 2024" report provides comprehensive insights about 25+ CRISPR Therapies Companies and 30+ pipeline drugs in CRISPR Therapies pipeline landscape. It covers the CRISPR Therapies pipeline drug profiles, including clinical and nonclinical stage products. It also covers the CRISPR Therapies therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive CRISPR Therapies pipeline products in this space.
Key Takeaways from…
Digital Therapeutics Market, Digital Therapeutics Market Size, Digital Therapeut …
The global digital therapeutics market is expected to reach US$ 8,941.1 Mn by 2025 from US$ 1,993.2 Mn in 2017. The market is estimated to grow with a CAGR of 20.8% during the forecast period from 2018 to 2025.
North America is the largest geographic market and it is expected to be the largest revenue generator during the forecast period, whereas the market is expected to witness growth at a significant…
